Promotions & Moves

Dragonfly Therapeutics Appoints Head of Biologics

Grinberg brings track record of scientific accomplishments and creativity in protein-based drug development

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dr. Asya Grinberg has been appointed head of biologics at Dragonfly Therapeutics, and joins the senior team. Dr. Grinberg will lead the protein engineering, purification, characterization and structural biology team.   Dr. Grinberg joins the company from Acceleron Pharma, where she led a multidisciplinary team in cell biology and protein chemistry. She most recently served as senior director of Cell Biology and Protein Chemistry and has been a strong scientific and strategic driver of internal...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters